Transcription of Biopharmaceutical Research & Development
{{id}} {{{paragraph}}}
The Process Behind New MedicinesBiopharmaceutical Research & Development : OUR INDUSTRY IS POISED TO TRANSLATE OUR MOST PROMISING SCIENTIFIC BREAKTHROUGHS INTO MEANINGFUL TREATMENTS CAPABLE OF TACKLING THE MOST URGENT AND VEXING MEDICAL CHALLENGES OF OUR TIMES. WE STAND COMMITTED TO DRIVING PROGRESS FOR PATIENTS TODAY AND HOPE FOR TOMORROW. - KENNETH C. FRAZIER, CHAIRMAN & CEO, MERCKPHASE IPHASE IIPHASE IIIPHASE IVIND SUBMITTEDNDA/BLA SUBMITTEDFDA APPROVALTENSHUNDREDSTHOUSANDSNUMBER OF VOLUNTEERSTHE Biopharmaceutical Research AND Development PROCESSKey: IND: Investigational New Drug Application, NDA: New Drug Application, BLA: Biologics License ApplicationPOTENTIAL NEW MEDICINES1 FDA-APPROVEDMEDICINEBASICRESEARCHDRUGDIS COVERYCLINICAL TRIALSFDA REVIEWPOST-APPROVALRESEARCH &MONITORINGPRE-CLINICALFor patients, new medicines offer fewer side effects, fewer hospitalizations, improved quality of life, increased productivity, and importantly, extended lives.
develop new medicines and to fund future research. Patents grant inventors the exclusive right with respect to their inventions without others being able to copy and sell it for a set period of time. Data exclusivity (DE)* runs concurrently with patents and prohibits third parties for a set period of time from
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}